Comparison of efficacy of anagliptin and alogliptin for lipid profile between type 2 diabetic patients
Not Applicable
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000018949
- Lead Sponsor
- niversity of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients using glinide and insulin therapy, those who were or may have been pregnant, and those with severe renal dysfunction (s-Cre levels: male>1.4mg/dl, female>1.2mg/dl) were excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change of LDL-C at 24 weeks
- Secondary Outcome Measures
Name Time Method